Han Shih Toh

There were several multi-billion dollar deals agreed between the two nations at the Beijing summit, however, while the establishment of boards of trade and investment could help, some are sceptical, with Chinese FDI into the US at historically low levels.

Chinese regulators have blocked Meta’s acquisition of AI firm Manus, and fined a Chinese food firm using new overseas listing rules, as tech security concerns rise.

Amid encouragement from China, countries in the region and international entities, are increasingly issuing large panda bonds to diversify from US dollar debt.

Several warnings, including from ratings agencies, have been issued, as the two giant Chinese property developers continue to struggle as losses mount.

At this year’s Two Sessions, Beijing has indicated it is slowing GDP growth to “high quality development”; rapid AI innovation is set to spur modernisation.

With the HKMA close to issuing licences, yuan-linked stablecoins could help boost the internationalisation of the Chinese currency.

Amid a structural shift towards Asia, Insilico Medicine's IPO in December was a significant moment for the exchange, while French biotech TheraVectys is understood to be considering a listing.

The Chinese property giant's debt woes will not seriously affect China’s property sector, according to analysts; however, a restructuring might be on the cards.

China’s new five-year plan for 2026–2030 marks a decisive policy shift, placing domestic consumption and reform at the core of its growth strategy.

Beijing is encouraging A-share listed firms to list in Hong Kong, while Trump’s policies are turning some US-listed Chinese companies to also go public on HKEX. The IPO momentum is continuing with four firms listing on October 28 in the SAR.